Jankovic J - Search Results

1

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.

Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S; Global Dysport Cervical Dystonia Study Group. Truong D, et al. Among authors: jankovic j. Parkinsonism Relat Disord. 2010 Jun;16(5):316-23. doi: 10.1016/j.parkreldis.2010.03.002. Epub 2010 Mar 31. Parkinsonism Relat Disord. 2010. PMID: 20359934 Clinical Trial.

2

Long-term botulinum toxin efficacy, safety, and immunogenicity.

Mejia NI, Vuong KD, Jankovic J. Mejia NI, et al. Among authors: jankovic j. Mov Disord. 2005 May;20(5):592-7. doi: 10.1002/mds.20376. Mov Disord. 2005. PMID: 15645481 Clinical Trial.

3

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Truong D, et al. Among authors: jankovic j. Mov Disord. 2005 Jul;20(7):783-91. doi: 10.1002/mds.20403. Mov Disord. 2005. PMID: 15736159 Clinical Trial.

4

Long-term prognosis of patients with psychogenic movement disorders.

Thomas M, Vuong KD, Jankovic J. Thomas M, et al. Among authors: jankovic j. Parkinsonism Relat Disord. 2006 Sep;12(6):382-7. doi: 10.1016/j.parkreldis.2006.03.005. Epub 2006 Jun 5. Parkinsonism Relat Disord. 2006. PMID: 16737838

5

Botulinum toxin injection for congenital muscular torticollis presenting in children and adults.

Collins A, Jankovic J. Collins A, et al. Among authors: jankovic j. Neurology. 2006 Sep 26;67(6):1083-5. doi: 10.1212/01.wnl.0000237336.65596.21. Neurology. 2006. PMID: 17000985 Clinical Trial.

6

Treatment of dystonia.

Adam OR, Jankovic J. Adam OR, et al. Among authors: jankovic j. Parkinsonism Relat Disord. 2007;13 Suppl 3:S362-8. doi: 10.1016/S1353-8020(08)70031-2. Parkinsonism Relat Disord. 2007. PMID: 18267265 Review.

7

Role of botulinum toxin in the treatment of cervical dystonia.

Molho E, Jankovic J, Lew M. Molho E, et al. Among authors: jankovic j. Neurol Clin. 2008 May;26 Suppl 1:43-53. doi: 10.1016/s0733-8619(08)80004-7. Neurol Clin. 2008. PMID: 18603167 Review. No abstract available.

8

Motor overflow and mirror dystonia.

Sitburana O, Wu LJ, Sheffield JK, Davidson A, Jankovic J. Sitburana O, et al. Among authors: jankovic j. Parkinsonism Relat Disord. 2009 Dec;15(10):758-61. doi: 10.1016/j.parkreldis.2009.05.003. Epub 2009 Jun 7. Parkinsonism Relat Disord. 2009. PMID: 19505838

9

Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.

Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B; NINDS NET-PD Investigators. Elble RJ, et al. Mov Disord. 2010 Jun 15;25(8):1082-6. doi: 10.1002/mds.22997. Mov Disord. 2010. PMID: 20131372 Free PMC article.

10

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.

Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S; U.S. XEOMIN Cervical Dystonia Study Group. Comella CL, et al. Among authors: jankovic j. J Neurol Sci. 2011 Sep 15;308(1-2):103-9. doi: 10.1016/j.jns.2011.05.041. Epub 2011 Jul 18. J Neurol Sci. 2011. PMID: 21764407 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,235 results

Search Page